pqq cofactor has been researched along with Innate Inflammatory Response in 14 studies
PQQ Cofactor: A pyrrolo-quinoline having two adjacent keto-groups at the 4 and 5 positions and three acidic carboxyl groups. It is a coenzyme of some DEHYDROGENASES.
pyrroloquinoline quinone : A pyrroloquinoline having oxo groups at the 4- and 5-positions and carboxy groups at the 2-, 7- and 9-positions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In rotenone-treated BV2 cells, PQQ dose-dependently decreased lactate dehydrogenase (LDH) release and suppressed the up-regulation of pro-inflammation factors, such as interleukin-1β (IL-1β), IL-6 and tumor necrosis factor-α (TNF-α) in the cultured media, as well as nitric oxide (NO) release induced by rotenone." | 5.56 | Pyrroloquinoline Quinone Inhibits Rotenone-Induced Microglia Inflammation by Enhancing Autophagy. ( Cheng, Q; Ding, F; Shen, M; Xu, H; Yu, S; Zhang, Q; Zhou, J, 2020) |
| "In rotenone-treated BV2 cells, PQQ dose-dependently decreased lactate dehydrogenase (LDH) release and suppressed the up-regulation of pro-inflammation factors, such as interleukin-1β (IL-1β), IL-6 and tumor necrosis factor-α (TNF-α) in the cultured media, as well as nitric oxide (NO) release induced by rotenone." | 1.56 | Pyrroloquinoline Quinone Inhibits Rotenone-Induced Microglia Inflammation by Enhancing Autophagy. ( Cheng, Q; Ding, F; Shen, M; Xu, H; Yu, S; Zhang, Q; Zhou, J, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (14.29) | 24.3611 |
| 2020's | 12 (85.71) | 2.80 |
| Authors | Studies |
|---|---|
| Qu, XF | 1 |
| Zhai, BZ | 1 |
| Hu, WL | 1 |
| Lou, MH | 1 |
| Chen, YH | 1 |
| Liu, YF | 1 |
| Chen, JG | 1 |
| Mei, S | 1 |
| You, ZQ | 1 |
| Liu, Z | 2 |
| Zhang, LJ | 1 |
| Zhang, YH | 1 |
| Wang, Y | 3 |
| Shafiq, M | 1 |
| Lone, ZR | 1 |
| Bharati, P | 1 |
| Mahapatra, S | 1 |
| Rai, P | 1 |
| Khandelwal, N | 1 |
| Gaikwad, AN | 1 |
| Jagavelu, K | 1 |
| Hanif, K | 1 |
| Min, Z | 1 |
| Zhou, J | 2 |
| Mao, R | 1 |
| Cui, B | 1 |
| Cheng, Y | 1 |
| Chen, Z | 1 |
| Wang, J | 1 |
| Zhang, S | 1 |
| Hu, L | 1 |
| Liu, K | 1 |
| Le, J | 1 |
| Tan, Y | 1 |
| Li, T | 1 |
| Xue, H | 1 |
| Wei, Y | 1 |
| Zhong, O | 1 |
| He, J | 1 |
| Zi, D | 1 |
| Lei, X | 2 |
| Deng, R | 1 |
| Luo, Y | 1 |
| Tang, M | 1 |
| Su, M | 1 |
| Cao, Y | 1 |
| Liu, Q | 1 |
| Tang, Z | 1 |
| Hao, J | 1 |
| Ni, X | 1 |
| Giunta, S | 1 |
| Wu, J | 1 |
| Shuang, X | 1 |
| Xu, K | 1 |
| Li, R | 1 |
| Zhang, W | 1 |
| Xia, S | 1 |
| Zhang, H | 2 |
| Li, J | 2 |
| Cao, C | 1 |
| Zhang, B | 2 |
| Yang, W | 2 |
| Shi, B | 2 |
| Shan, A | 2 |
| Lin, X | 1 |
| Yang, F | 1 |
| Huang, J | 2 |
| Jiang, S | 1 |
| Tang, Y | 1 |
| Devasani, K | 1 |
| Kaul, R | 1 |
| Majumdar, A | 1 |
| Wang, C | 1 |
| Meng, Q | 1 |
| Zhang, Q | 1 |
| Shen, M | 1 |
| Xu, H | 1 |
| Yu, S | 1 |
| Cheng, Q | 1 |
| Ding, F | 1 |
| Liu, L | 1 |
| Zhang, Y | 1 |
| Liu, T | 1 |
| Ke, C | 1 |
| Fu, Y | 1 |
| Lin, Z | 2 |
| Chen, F | 1 |
| Wu, X | 1 |
| Chen, Q | 1 |
| Wu, Y | 1 |
| Zhao, M | 1 |
| Harris, CB | 1 |
| Chowanadisai, W | 1 |
| Mishchuk, DO | 1 |
| Satre, MA | 1 |
| Slupsky, CM | 1 |
| Rucker, RB | 1 |
| Sun, C | 1 |
| Tao, R | 1 |
| Xu, X | 1 |
| Xu, L | 1 |
| Cheng, H | 1 |
| Zhang, D | 1 |
14 other studies available for pqq cofactor and Innate Inflammatory Response
| Article | Year |
|---|---|
Pyrroloquinoline quinone ameliorates diabetic cardiomyopathy by inhibiting the pyroptosis signaling pathway in C57BL/6 mice and AC16 cells.
Topics: Animals; Cardiomegaly; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Fibrosis; Glucose | 2022 |
Pyrroloquinoline quinone (PQQ) improves pulmonary hypertension by regulating mitochondrial and metabolic functions.
Topics: Animals; Endothelial Cells; Humans; Hypertension, Pulmonary; Inflammation; Monocrotaline; PQQ Cofact | 2022 |
Pyrroloquinoline Quinone Administration Alleviates Allergic Airway Inflammation in Mice by Regulating the JAK-STAT Signaling Pathway.
Topics: Animals; Asthma; Bronchoalveolar Lavage Fluid; Cytokines; Disease Models, Animal; Inflammation; Janu | 2022 |
Pyrroloquinoline quinone inhibits PCSK9-NLRP3 mediated pyroptosis of Leydig cells in obese mice.
Topics: Animals; Humans; Inflammation; Leydig Cells; Male; Mice; Mice, Obese; NLR Family, Pyrin Domain-Conta | 2023 |
Pyrroloquinoline quinone delays inflammaging induced by TNF-α through the p16/p21 and Jagged1 signalling pathways.
Topics: Anti-Inflammatory Agents; Antioxidants; Cells, Cultured; Cellular Senescence; Cyclin-Dependent Kinas | 2020 |
Pyrroloquinoline quinone inhibits the production of inflammatory cytokines via the SIRT1/NF-κB signal pathway in weaned piglet jejunum.
Topics: Animal Feed; Animals; Animals, Newborn; Antioxidants; Cytokines; Dietary Supplements; Inflammation; | 2020 |
Ameliorate effect of pyrroloquinoline quinone against cyclophosphamide-induced nephrotoxicity by activating the Nrf2 pathway and inhibiting the NLRP3 pathway.
Topics: Animals; Antioxidants; Blood Urea Nitrogen; Body Weight; Creatinine; Cyclophosphamide; Cytokines; In | 2020 |
Supplementation of pyrroloquinoline quinone with atorvastatin augments mitochondrial biogenesis and attenuates low grade inflammation in obese rats.
Topics: Animals; Anti-Inflammatory Agents; Atorvastatin; Blood Glucose; Cytokines; Disease Models, Animal; D | 2020 |
Effect of dietary pyrroloquinoline quinone disodium in sows on intestinal health of the offspring.
Topics: Animal Nutritional Physiological Phenomena; Animals; Animals, Newborn; Antioxidants; Cytokines; Diet | 2020 |
Pyrroloquinoline Quinone Inhibits Rotenone-Induced Microglia Inflammation by Enhancing Autophagy.
Topics: Anti-Inflammatory Agents; Autophagy; Cell Line, Tumor; Cell Survival; Humans; Inflammation; Microgli | 2020 |
Pyrroloquinoline quinone protects against exercise-induced fatigue and oxidative damage via improving mitochondrial function in mice.
Topics: Animals; Cell Line; Cell Survival; Fatigue; Gene Expression Regulation; Inflammation; Male; Mice; Mi | 2021 |
Pyrroloquinoline quinone (PQQ) alleviated sepsis-induced acute liver injury, inflammation, oxidative stress and cell apoptosis by downregulating CUL3 expression.
Topics: Acute Disease; Animals; Apoptosis; Cullin Proteins; Down-Regulation; Inflammation; Kupffer Cells; Li | 2021 |
Dietary pyrroloquinoline quinone (PQQ) alters indicators of inflammation and mitochondrial-related metabolism in human subjects.
Topics: Adult; Antioxidants; Aspartate Aminotransferases; Blood Glucose; C-Reactive Protein; Cholesterol; Cr | 2013 |
Pyrroloquinoline Quinone Decelerates Rheumatoid Arthritis Progression by Inhibiting Inflammatory Responses and Joint Destruction via Modulating NF-κB and MAPK Pathways.
Topics: Active Transport, Cell Nucleus; Animals; Ankle Joint; Antioxidants; Arthritis, Experimental; Arthrit | 2016 |